Knight Cancer Institute, Cancer Early Detection Advanced Research Center (CEDAR), Oregon Health & Science University, Portland, OR, 97201, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, 97239, USA.
Sci Rep. 2020 Oct 5;10(1):16456. doi: 10.1038/s41598-020-73350-3.
Many emerging technologies are reliant on circulating cell-free DNA (cfDNA) and cell-free RNA (cfRNA) applications in the clinic. However, the impact of diurnal cycles or daily meals on circulating analytes are poorly understood and may be confounding factors when developing diagnostic platforms. To begin addressing this knowledge gap, we obtained plasma from four healthy donors serially sampled five times during 12 h in a single day. For all samples, we measured concentrations of cfDNA and cfRNA using both bulk measurements and gene-specific digital droplet PCR. We found no significant variation attributed to blood draw number for the cfDNA or cfRNA. This indicated that natural diurnal cycles and meal consumption do not appear to significantly affect abundance of total cfDNA, total cfRNA, or our two selected cfRNA transcripts. Conversely, we observed significant variation between individual donors for cfDNA and one of the cfRNA transcripts. The results of this work suggest that it will be important to consider patient-specific baselines when designing reliable circulating cfDNA or cfRNA clinical assays.
许多新兴技术依赖于循环无细胞 DNA (cfDNA) 和循环无细胞 RNA (cfRNA) 在临床上的应用。然而,昼夜节律或日常饮食对循环分析物的影响还知之甚少,在开发诊断平台时可能是混杂因素。为了开始解决这一知识空白,我们从四名健康供体中获得血浆,在一天中的 12 小时内连续五次采样。对于所有样本,我们使用批量测量和基因特异性数字液滴 PCR 测量 cfDNA 和 cfRNA 的浓度。我们发现 cfDNA 或 cfRNA 的采血次数没有明显的变化。这表明自然昼夜节律和进餐似乎不会显著影响总 cfDNA、总 cfRNA 或我们选择的两种 cfRNA 转录本的丰度。相反,我们观察到 cfDNA 和一种 cfRNA 转录本在个体供体之间存在显著差异。这项工作的结果表明,在设计可靠的循环 cfDNA 或 cfRNA 临床检测时,考虑患者特定的基线将非常重要。